TP53 and lung cancer: In lung cancer, Storozhuk et al. noticed that metformin combined with IR maintains the activation of ATM–AMPK–p53/p21cip1 and inhibition of Akt–mTOR–4EBP1 pathways, and causes the inhibition of angiogenesis and induction of apoptosis [57].